NeuroSense Reports Additional Positive Results from its ALS

PrimeC demonstrated a clinically meaningful effect on quality of life and on complication free-survival for patients with ALSStandard ALS Measure ALSFRS-R already demonstrated a statistically...

Related Keywords

Cambridge , Cambridgeshire , United Kingdom , Israel , Canada , Italy , Ferenc Tracik , Prnewswire Neurosense Therapeutics Ltd , European Medicines Agency , Linkedin , Drug Administration , Neurosense Therapeutics Ltd , Exchange Commission On , Exchange Commission , Nasdaq , Sense Therapeutics , Advanced Stage Free Survival , Chief Medical , Rating Scale Revised , Slow Vital Capacity , Per Protocol , Alon Ben Noon , Orphan Drug Designation , European Medicines , Investigator Initiated Trial , Tos Advanced Stage Free Survival , Tos Advanced Stage , Neurosense Therapeutic , Annual Report , Neurosense Therapeutics , Markets ,